Olmesartan Medoxomil
- Product NDC
- 62135-881
- 11-digit product format
- 621350881
- Labeler code
- 62135
- Product ID
- 62135-881_46879df5-2a7d-8b49-e063-6294a90ad4b7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olmesartan Medoxomil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA211049
- Marketing category
- ANDA
- Marketing start
- 2019-03-05
- Substance
- OLMESARTAN MEDOXOMIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211049-001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | |
| A211049-002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | |
| A211049-003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211049-001 | AB |
| A211049-002 | AB |
| A211049-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211049-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2019-02-22 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211049-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2019-02-22 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A211049-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2019-02-22 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211049-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211049-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211049-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211049-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211049-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211049-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211049-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211049-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211049-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211049-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211049-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211049-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211049-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211049-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211049-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211049-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211049-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211049-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211049-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211049-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211049-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211049-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211049-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211049-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211049-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211049-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211049-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A211049-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211049-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211049-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211049-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211049-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211049-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211049-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211049-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211049-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211049-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211049-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211049-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A211049-001 | AB | 1 | 8072bd15b7f6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olmesartan Medoxomil
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OLMESARTAN MEDOXOMIL | 20 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6M97XTV3HD | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c19ec24d-2c40-4b8d-7c20-500ffa3660a1 | Product name | 3 | 20260303 |
| 96816964-c075-ffa7-b7b8-d8570411a3b9 | Product name | 7 | 20250305 |
| caadbc51-b731-1a7b-b91a-f7bb4a62554e | Product name | 9 | 20240306 |
| 4a27501f-a987-48a5-99b4-e983d4744d76 | Product name | 7 | 20181211 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62135-881-30 | Olmesartan Medoxomil | 30 in 1 BOTTLE | TABLET | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62135-881-30 | EA - Each | 62135-881 | 43d39a07-2200-4b78-ab91-488f733a7a30 | 1 | 2024-05-16 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | HEC Pharm USA Inc. | 4f4d89ab-58c8-27ea-e063-6394a90a8723 | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 211049 ANDA211049 |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Chartwell RX, LLC | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 211049 ANDA211049 62135-881 |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 3c001b8d-f6c1-4316-b8c0-590b2fa7f2e5 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 211049 ANDA211049 |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 38f7f201-3a3a-4922-bde7-d34187b4c81d | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 211049 ANDA211049 |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | c620361a-dc2d-28a1-e053-2995a90abd14 | 2024-10-29 | Boxed warning, Warnings, Adverse reactions | 211049 ANDA211049 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349401 | olmesartan medoxomil 20 MG Oral Tablet | PSN | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2 |
| 349405 | olmesartan medoxomil 40 MG Oral Tablet | PSN | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2 |
| 349373 | olmesartan medoxomil 5 MG Oral Tablet | PSN | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2 |
| 349401 | olmesartan medoxomil 20 MG Oral Tablet | SCD | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2 |
| 349405 | olmesartan medoxomil 40 MG Oral Tablet | SCD | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2 |
| 349373 | olmesartan medoxomil 5 MG Oral Tablet | SCD | 7835d2b0-8e5d-4d3f-a95f-9252fb65025b | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 62135-881-30 | 62135088130 | 30 TABLET in 1 BOTTLE (62135-881-30) | 30 tablet | 2024-04-05 | No | No | Current |